Beaton Management Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.35M | Hold |
8,873
| – | – | 0.6% | 49 |
|
|
2025
Q4 | $1.22M | Hold |
8,873
| – | – | 0.54% | 52 |
|
|
2025
Q3 | $1.14M | Hold |
8,873
| – | – | 0.52% | 55 |
|
|
2025
Q2 | $1.07M | Hold |
8,873
| – | – | 0.52% | 57 |
|
|
2025
Q1 | $989K | Hold |
8,873
| – | – | 0.51% | 58 |
|
|
2024
Q4 | $863K | Hold |
8,873
| – | – | 0.44% | 62 |
|
|
2024
Q3 | $1.02M | Hold |
8,873
| – | – | 0.52% | 57 |
|
|
2024
Q2 | $945K | Hold |
8,873
| – | – | 0.51% | 58 |
|
|
2024
Q1 | $858K | Hold |
8,873
| – | – | 0.47% | 63 |
|
|
2023
Q4 | $896K | Hold |
8,873
| – | – | 0.54% | 58 |
|
|
2023
Q3 | $904K | Hold |
8,873
| – | – | 0.59% | 54 |
|
|
2023
Q2 | $895K | Hold |
8,873
| – | – | 0.57% | 57 |
|
|
2023
Q1 | $816K | Sell |
8,873
-170
| -2% | -$14.8K | 0.55% | 57 |
|
|
2022
Q4 | $820K | Hold |
9,043
| – | – | 0.55% | 60 |
|
|
2022
Q3 | $687K | Sell |
9,043
-476
| -5% | -$39.5K | 0.52% | 60 |
|
|
2022
Q2 | $805K | Hold |
9,519
| – | – | 0.57% | 56 |
|
|
2022
Q1 | $835K | Buy |
9,519
+172
| +2% | +$14.9K | 0.52% | 60 |
|
|
2021
Q4 | $818K | Hold |
9,347
| – | – | 0.49% | 58 |
|
|
2021
Q3 | $764K | Sell |
9,347
-100
| -1% | -$9K | 0.51% | 59 |
|
|
2021
Q2 | $862K | Hold |
9,447
| – | – | 0.55% | 60 |
|
|
2021
Q1 | $808K | Sell |
9,447
-226
| -2% | -$20.3K | 0.56% | 57 |
|
|
2020
Q4 | $913K | Sell |
9,673
-176
| -2% | -$15.4K | 0.67% | 48 |
|
|
2020
Q3 | $856K | Hold |
9,849
| – | – | 0.71% | 46 |
|
|
2020
Q2 | $860K | Buy |
9,849
+150
| +2% | +$12.9K | 0.77% | 44 |
|
|
2020
Q1 | $800K | Buy |
9,699
+124
| +1% | +$11.1K | 0.8% | 46 |
|
|
2019
Q4 | $907K | Buy |
9,575
+12
| +0.1% | +$1.08K | 0.71% | 48 |
|
|
2019
Q3 | $831K | Buy |
9,563
+80
| +0.8% | +$7.18K | 0.67% | 50 |
|
|
2019
Q2 | $866K | Sell |
9,483
-1,197
| -11% | -$101K | 0.72% | 46 |
|
|
2019
Q1 | $920K | Sell |
10,680
-97
| -0.9% | -$7.79K | 0.8% | 44 |
|
|
2018
Q4 | $829K | Hold |
10,777
| – | – | 0.81% | 43 |
|
|
2018
Q3 | $932K | Hold |
10,777
| – | – | 0.77% | 45 |
|
|
2018
Q2 | $729K | Hold |
10,777
| – | – | 0.65% | 51 |
|
|
2018
Q1 | $781K | Hold |
10,777
| – | – | 0.72% | 50 |
|
|
2017
Q4 | $811K | Sell |
10,777
-84
| -0.8% | -$6.34K | 0.73% | 45 |
|
|
2017
Q3 | $835K | Buy |
10,861
+195
| +2% | +$14.7K | 0.79% | 38 |
|
|
2017
Q2 | $798K | Buy |
+10,666
| New | +$756K | 0.79% | 38 |
|
Other funds holding NVS
Beaton Management Company's NVS Position: Q1 2026 in Review
Beaton Management Company held its Novartis (NVS) position steady in Q1 2026 at 8,873 shares worth $1.35M. The position accounts for 0.6% of the portfolio, ranked #49.
Beaton Management Company first reported a position in NVS in Q2 2017 and has held it in 36 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Beaton Management Company held 8,873 shares of Novartis worth $1.35M as of Q1 2026.
- Beaton Management Company left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.6% of Beaton Management Company's portfolio in Q1 2026, its #49 holding.
- Beaton Management Company first reported a position in Novartis in Q2 2017 and has held it in 36 quarters since.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Beaton Management Company's 13F filing for Q1 2026, filed 12 May 2026.